- Home
- MRC vs CRMD Comparison
MRC vs CRMD Comparison
Compare MRC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRC
- CRMD
- Stock Information
- Founded
- MRC 1921
- CRMD 2006
- Country
- MRC United States
- CRMD United States
- Employees
- MRC N/A
- CRMD N/A
- Industry
- MRC Industrial Machinery/Components
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- MRC Industrials
- CRMD Health Care
- Exchange
- MRC Nasdaq
- CRMD Nasdaq
- Market Cap
- MRC 1.1B
- CRMD 901.8M
- IPO Year
- MRC 2012
- CRMD 2010
- Fundamental
- Price
- MRC $15.09
- CRMD $14.83
- Analyst Decision
- MRC Strong Buy
- CRMD Strong Buy
- Analyst Count
- MRC 3
- CRMD 7
- Target Price
- MRC $16.00
- CRMD $16.83
- AVG Volume (30 Days)
- MRC 664.0K
- CRMD 3.7M
- Earning Date
- MRC 08-06-2025
- CRMD 08-07-2025
- Dividend Yield
- MRC N/A
- CRMD N/A
- EPS Growth
- MRC N/A
- CRMD N/A
- EPS
- MRC N/A
- CRMD 0.79
- Revenue
- MRC $2,945,000,000.00
- CRMD $121,484,498.00
- Revenue This Year
- MRC $5.81
- CRMD $404.81
- Revenue Next Year
- MRC $5.43
- CRMD $56.11
- P/E Ratio
- MRC N/A
- CRMD $18.74
- Revenue Growth
- MRC N/A
- CRMD 14970.29
- 52 Week Low
- MRC $9.23
- CRMD $5.31
- 52 Week High
- MRC $15.59
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- MRC 60.32
- CRMD 73.44
- Support Level
- MRC $14.66
- CRMD $13.66
- Resistance Level
- MRC $15.08
- CRMD $14.44
- Average True Range (ATR)
- MRC 0.37
- CRMD 0.68
- MACD
- MRC 0.11
- CRMD 0.24
- Stochastic Oscillator
- MRC 81.01
- CRMD 97.22
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.